Autonomix Medical (AMIX) Common Equity (2022 - 2025)

Autonomix Medical (AMIX) has 4 years of Common Equity data on file, last reported at $8.6 million in Q4 2025.

• On a quarterly basis, Common Equity fell 11.81% year-over-year to $8.6 million in Q4 2025; TTM through Dec 2025 was $8.6 million, a 11.81% decrease from a year earlier, with the FY2025 full-year figure at $8.1 million, up 6.17% from the prior year.
• Common Equity for Q4 2025 stood at $8.6 million, up from $6.4 million in the prior quarter.
• Over the last five years, Common Equity for AMIX reached as high as $9.7 million in Q4 2024 and fell as low as -$5.6 million in Q4 2023.
• Historically, Common Equity has averaged $3.9 million across 4 years, with a median of $5.3 million in 2024.
• Across the five-year window, Common Equity sank 993.77% in 2023 and soared 1084.47% in 2024, its largest moves.
• Year by year, Common Equity stood at $626000.0 in 2022, then sank by 993.77% to -$5.6 million in 2023, then jumped by 273.49% to $9.7 million in 2024, then retreated by 11.81% to $8.6 million in 2025.
• Per Business Quant data, the three most recent Common Equity figures were $8.6 million in Q4 2025, $6.4 million in Q3 2025, and $7.0 million in Q2 2025.